Literature DB >> 19454440

Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.

K Oberg1, S Jelic.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19454440     DOI: 10.1093/annonc/mdp158

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

1.  In reply.

Authors:  James Yao; Diane Reidy Lagunes; Matthew H Kulke
Journal:  Oncologist       Date:  2013

2.  Further Classification for Node-Positive Gastric Neuroendocrine Neoplasms.

Authors:  Linda M Pak; Tingsong Yang; Jiping Wang
Journal:  J Gastrointest Surg       Date:  2018-06-27       Impact factor: 3.452

3.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

Review 4.  Potential synergies for combined targeted therapy in the treatment of neuroendocrine cancer.

Authors:  Ramon Salazar; Diane Reidy-Lagunes; James Yao
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 5.  Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.

Authors:  Ting-Ting Li; Feng Qiu; Zhi Rong Qian; Jun Wan; Xiao-Kun Qi; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 6.  Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.

Authors:  Omar Abdel-Rahman
Journal:  Tumour Biol       Date:  2014-09-18

7.  Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.

Authors:  William J Salyers; Kenneth J Vega; Juan Carlos Munoz; Bruce W Trotman; Silvio S Tanev
Journal:  World J Gastrointest Oncol       Date:  2014-08-15

Review 8.  New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors.

Authors:  Ben Lawrence; Bjorn I Gustafsson; Mark Kidd; Irvin Modlin
Journal:  Gastroenterol Clin North Am       Date:  2010-09       Impact factor: 3.806

Review 9.  Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.

Authors:  Omar Abdel-Rahman; Mona Fouad
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-03       Impact factor: 4.553

10.  Molecular challenges of neuroendocrine tumors.

Authors:  Parthik Patel; Karina Galoian
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.